Khamashta MA. Hughes syndrome: sticky blood. Clin Exp Rheum 2009;27:1-2.

Emson HE. For the want of an heir: the obstetrical history of Queen Anne. BMJ 1992;304:1365-6. DOI: https://doi.org/10.1136/bmj.304.6838.1365

Wasserman A, Neisser A, Bruck C. Eine serodiagnostische reaktion bei syphilis. Dtsh Med Wochenschr 1906;32:745. DOI: https://doi.org/10.1055/s-0028-1142018

Asherson RA, Cervera R, Piette JC, et al. The antiphospholipid syndrome: history, definition, classification and differential diagnosis. In: Asherson RA. The antiphospholid syndrome. Boca Raton, FL: CRC Press; 1996. pp 3-12. DOI: https://doi.org/10.1201/9781351077125-1

Pagborn MC. A new serologically active phospholipid from beef heart. Proc Soc Exp Biol Med 1941;44:484-6. DOI: https://doi.org/10.3181/00379727-48-13365P

Moore JE, Mohr CF. Biologically false positive serologic tests for syphilis; type, incidence, and cause. J Am Med Assoc 1952;150:467-73. DOI: https://doi.org/10.1001/jama.1952.03680050033010

Moore JE, Lutz WB. The natural history of systemic lupus erythematosus: an approach to its study through chronic biologic false positive reactors. J Chronic Dis 1955;1:297-316. DOI: https://doi.org/10.1016/0021-9681(55)90039-4

Conley CL, Hartmann RC. A hemorrhagic disorder caused by circulation anticoagulant in patients with disseminate lupus erythematosus. J Lab Clin Invest 1952;31:621-2.

Laurell AB, Nilsson IM. Hypergammaglobulinemia, circulating anticoagulant, and biologic false positive Wassermann reaction; a study in two cases. J Lab Clin Med 1957;49:694-707.

Lee SL, Sanders MA. A disorder of blood coagulation in systemic lupus erythematosus. J Clin Invest 1955;34:1814-22. DOI: https://doi.org/10.1172/JCI103237

Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972;1:75-95.

Bowie EJ, Thompson JH Jr, Pascuzzi CA, et al. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963;62:416-30.

Alarcon Segovia D, Osmundson PJ. Peripheral vascular syndromes associated with systemic lupus erythematosus. Ann Intern Med 1965;62:907-19. DOI: https://doi.org/10.7326/0003-4819-62-5-907

Beaumont JL. Acquired hemorrhagic syndrome caused by a circulating anticoagulant; inhibition of the thromboplastic function of the blood platelets; description of a specific test [Aricle in French]. Sang 1954;25:1-15.

Nilsson IM, Astedt B, Hedner U, et al. Intrauterine death and circulating anticoagulant ("antithromboplastin"). Acta Med Scand 1975;197:153-9. DOI: https://doi.org/10.1111/j.0954-6820.1975.tb04897.x

Krulik M, Tobelem G, Audebert AA, et al. Circulating anticoagulants in disseminated lupus erythematosus. [Article in French]. Ann Med Interne 1977;128:57-62.

Soulier JP, Boffa MC. Avortements á repetition, thromboses et anticoagulant circulant antithromboplastine. Nouv Presse Med 1980;9:859-64.

Carreras LO, Vermylen J, Spitz B, et al. "Lupus" anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol 1981;88:890-4. DOI: https://doi.org/10.1111/j.1471-0528.1981.tb02224.x

Carreras LO, Defreyn G, Machin SJ, et al. Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981;1:244-6. DOI: https://doi.org/10.1016/S0140-6736(81)92087-0

Hughes GR. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) 1983;287:1088-9. DOI: https://doi.org/10.1136/bmj.287.6399.1088

Lubbe WF, Butler WS, Palmer SJ, et al. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet 1983;1:1361-3. DOI: https://doi.org/10.1016/S0140-6736(83)92141-4

Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;2:1211-4. DOI: https://doi.org/10.1016/S0140-6736(83)91267-9

Harris EN, Gharavi AE, Hughes GR. Anti-phospholipid antibodies. Clin Rheum Dis 1985;11:591-609. DOI: https://doi.org/10.1016/S0307-742X(21)00606-8

Mackworth-Young CG, Loizou S, Walport MJ. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies but with no other disorder. Ann Rheum Dis 1989;48:362-7. DOI: https://doi.org/10.1136/ard.48.5.362

Alarcon-Segovia D, Sanchez-Guerrero J. Primary antiphospholipid syndrome. J Rheumatol 1989;16:482-8.

Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-7. DOI: https://doi.org/10.1016/0140-6736(90)91374-J

McNeil HP, Simpson RJ, Chesterman CN, et al. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 1990;87:4120-4. DOI: https://doi.org/10.1073/pnas.87.11.4120

Matsuura E, Igarashi Y, Fujimoto M, et al. Anticardiolipin cofactor(s) and differential diagnosis of antoimmune disease. Lancet 1990;336:177-8. DOI: https://doi.org/10.1016/0140-6736(90)91697-9

Arvieux J, Roussel B, Jacob MC, et al. Measurement of anti-phospholipid antibodies by ELISA using beta 2-glycoprotein I as an antigen. J Immunol Methods 1991;143:223-9. DOI: https://doi.org/10.1016/0022-1759(91)90047-J

Gharavi AE, Mellors RC, Elkon KB. IgG anti-cardiolipin antibodies in murine lupus. Clin Exp Immunol 1989;78:233-8.

Branch DW, Dudley DJ, Mitchell MD, et al. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 1990;163:210-6. DOI: https://doi.org/10.1016/S0002-9378(11)90700-5

Blank M, Cohen J, Toder V, et al. Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc Natl Acad Sci U S A 1991;88:3069-73. DOI: https://doi.org/10.1073/pnas.88.8.3069

Pierangeli SS, Harris EN. Antiphospholipid antibodies in an in vivo thrombosis model in mice. Lupus 1994;3:247-51. DOI: https://doi.org/10.1177/096120339400300408

Holers VM, Girardi G, Mo L, et al. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002;195:211–20. DOI: https://doi.org/10.1084/jem.200116116

Meroni PL, del Papa N, Gambini D, et al. Antiphospholipid antibodies and endothelial cells. Lupus 1994;3:267-9. DOI: https://doi.org/10.1177/096120339400300412

Di Simone N, Meroni PL, de Papa N, et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000;43:140-50. DOI: https://doi.org/10.1002/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P

Asherson R A. The catastrophic antiphospholipid syndrome. J Rheumatol 1992;19:508-12.

Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11. DOI: https://doi.org/10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F

Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306. DOI: https://doi.org/10.1111/j.1538-7836.2006.01753.x

Barbhaiya M, Zuily S, Ahmadzadeh Y, et al. Development of a new international antiphospholipid syndrome classification criteria phase I/II report: generation and reduction of candidate criteria. Arthritis Care Res (Hoboken) 2021;73:1490-1501. DOI: https://doi.org/10.1002/acr.24520

Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002;46:1019–27. DOI: https://doi.org/10.1002/art.10187

Erkan D, Lockshin MD, APS ACTION members. APS ACTION--antiphospholipid syndrome alliance for clinical trials and international networking. Lupus 2012;21:695-8. DOI: https://doi.org/10.1177/0961203312437810